Legato Capital Management LLC raised its stake in shares of Steris PLC (NYSE:STE) by 6,926.1% during the first quarter, Holdings Channel reports. The fund owned 5,944,248 shares of the medical equipment provider’s stock after buying an additional 5,859,646 shares during the period. Steris PLC comprises about 2.1% of Legato Capital Management LLC’s investment portfolio, making the stock its 8th largest position. Legato Capital Management LLC owned approximately 0.07% of Steris PLC worth $85,578,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Capstone Asset Management Co. raised its position in Steris PLC by 0.5% in the third quarter. Capstone Asset Management Co. now owns 8,820 shares of the medical equipment provider’s stock valued at $645,000 after buying an additional 40 shares during the last quarter. CENTRAL TRUST Co raised its position in Steris PLC by 1.3% in the first quarter. CENTRAL TRUST Co now owns 3,670 shares of the medical equipment provider’s stock valued at $255,000 after buying an additional 47 shares during the last quarter. Sawtooth Solutions LLC raised its position in Steris PLC by 1.3% in the third quarter. Sawtooth Solutions LLC now owns 4,600 shares of the medical equipment provider’s stock valued at $336,000 after buying an additional 57 shares during the last quarter. Raymond James Trust N.A. raised its position in Steris PLC by 1.3% in the first quarter. Raymond James Trust N.A. now owns 5,473 shares of the medical equipment provider’s stock valued at $380,000 after buying an additional 71 shares during the last quarter. Finally, Advantus Capital Management Inc raised its position in Steris PLC by 1.0% in the third quarter. Advantus Capital Management Inc now owns 10,515 shares of the medical equipment provider’s stock valued at $769,000 after buying an additional 100 shares during the last quarter. 89.63% of the stock is currently owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Steris PLC (NYSE:STE)

Steris PLC (NYSE:STE) traded down 0.37% on Tuesday, reaching $69.76. The company had a trading volume of 98,182 shares. Steris PLC has a 12 month low of $63.26 and a 12 month high of $74.63. The firm has a 50 day moving average price of $69.28 and a 200-day moving average price of $68.63. The stock has a market capitalization of $5.92 billion, a price-to-earnings ratio of 42.43 and a beta of 1.30.

Steris PLC (NYSE:STE) last announced its quarterly earnings data on Tuesday, February 7th. The medical equipment provider reported $0.98 EPS for the quarter, missing the Zacks’ consensus estimate of $1.04 by $0.06. The firm earned $646.80 million during the quarter, compared to the consensus estimate of $680.13 million. Steris PLC had a net margin of 5.39% and a return on equity of 10.34%. The firm’s quarterly revenue was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.98 earnings per share. Analysts forecast that Steris PLC will post $3.73 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 28th. Shareholders of record on Tuesday, February 28th were given a $0.28 dividend. The ex-dividend date was Friday, February 24th. This represents a $1.12 dividend on an annualized basis and a yield of 1.60%. Steris PLC’s payout ratio is 68.29%.

WARNING: This piece was posted by Daily Political and is the property of of Daily Political. If you are reading this piece on another website, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece can be read at https://www.dailypolitical.com/2017/04/18/steris-plc-ste-shares-bought-by-legato-capital-management-llc.html.

Separately, Zacks Investment Research raised Steris PLC from a “sell” rating to a “hold” rating in a research report on Friday, March 31st.

In other Steris PLC news, Director Mohsen Sohi sold 3,387 shares of the stock in a transaction on Monday, February 13th. The stock was sold at an average price of $67.66, for a total value of $229,164.42. Following the transaction, the director now directly owns 24,421 shares in the company, valued at approximately $1,652,324.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 2.52% of the stock is currently owned by company insiders.

About Steris PLC

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

5 Day Chart for NYSE:STE

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).

Receive News & Ratings for Steris PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris PLC and related companies with MarketBeat.com's FREE daily email newsletter.